homovanillic acid has been researched along with Alzheimer Disease in 98 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study we investigated the cerebrospinal fluid (CSF) concentrations of 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) in Alzheimer (AD) patients (n=75), patients with mild cognitive impairment (MCI, n=9) and patients with depression (n=7)." | 7.72 | 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment. ( Ganzer, S; Müller-Thomsen, T; Stuerenburg, HJ, 2004) |
| "Cerebrospinal fluid (CSF) concentration of beta-endorphin (beta-Ep), homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) was measured in 15 patients with dementia of the Alzheimer type (DAT) and in 16 patients suspected of having Binswanger's disease (BD) by MRI, which sometimes resembles DAT clinically." | 7.68 | CSF beta-endorphin, HVA and 5-HIAA of dementia of the Alzheimer type and Binswanger's disease in the elderly. ( Chiba, T; Hagiwara, M; Kaieda, R; Kitahama, T; Lee, S; Nagazumi, A; Terashi, A, 1990) |
| "It is concluded that in severe forms of senile dementia of Alzheimer type, there is a decrease in the levels of HVA and 5-HIAA in CSF which may reflect a decreased turnover of dopamine and serotonin." | 5.26 | Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type. ( MacDonald, E; Rekonen, M; Riekkinen, PJ; Soininen, H, 1981) |
| "Five patients with the early-onset form of Alzheimer disease (AD) received GM1 ganglioside by continuous injection into the frontal horns of the lateral ventricles for a period of 12 months." | 5.10 | Alzheimer disease - effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme. ( Bråne, G; Karlsson, I; Lekman, A; Ramström, I; Svennerholm, L; Wikkelsö, C, 2002) |
| "In this study we investigated the cerebrospinal fluid (CSF) concentrations of 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) in Alzheimer (AD) patients (n=75), patients with mild cognitive impairment (MCI, n=9) and patients with depression (n=7)." | 3.72 | 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment. ( Ganzer, S; Müller-Thomsen, T; Stuerenburg, HJ, 2004) |
| "Cerebrospinal fluid (CSF) concentration of beta-endorphin (beta-Ep), homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) was measured in 15 patients with dementia of the Alzheimer type (DAT) and in 16 patients suspected of having Binswanger's disease (BD) by MRI, which sometimes resembles DAT clinically." | 3.68 | CSF beta-endorphin, HVA and 5-HIAA of dementia of the Alzheimer type and Binswanger's disease in the elderly. ( Chiba, T; Hagiwara, M; Kaieda, R; Kitahama, T; Lee, S; Nagazumi, A; Terashi, A, 1990) |
| "A distinct pattern of neuropsychological deficits was associated with low homovanillic acid (HVA) in the cerebrospinal fluid of 21 patients with: Alzheimer's disease (9), Parkinson's disease (8) and major depressive disorders (4)." | 3.68 | Neuropsychological profile linked to low dopamine: in Alzheimer's disease, major depression, and Parkinson's disease. ( Albert, ML; Almozlino, A; Durso, R; Katz, DI; Smith, MC; Volicer, L; Wolfe, N, 1990) |
| "Changes in the activity of neurotransmitters in dementia were studied by measuring the activities of each of choline acetyltransferase (CAT), dopamine-beta-hydroxylase (DBH) and hydroxylase cofactor (tetrahydrobiopterine; BPH4), and the concentrations of homovanillic acid (HVA) and vasopressin." | 3.67 | Neurotransmitters in dementia. ( Fujiyoshi, K; Iijima, S; Kato, T; Koshimura, K; Miyata, S; Nagata, H; Nakamura, S; Okamoto, K; Suga, H; Yamao, S, 1984) |
| " Lumbar cerebrospinal fluid (CSF) neurotransmitter metabolite levels for homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA), and 3-methoxy-4-hydroxyphenyl glycol (MHPG) were determined in patients with schizophrenia and Alzheimer's disease." | 3.67 | Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations. ( Davis, KL; Losonczy, MF; Mohs, RC, 1984) |
| " We tested patients with PD, patients with Alzheimer's type of senile dementia, and a control group neuropsychologically, and we determined their CSF levels of homovanillic acid, 3,4-dihydroxyphenylacetic acid, 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindolacetic acid, serotonin, and acetylcholinesterase." | 3.67 | Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings. ( Albert, ML; Direnfeld, LK; Kaplan, E; Langlais, PJ; Marquis, J; Volicer, L, 1984) |
| "Patients with Alzheimer disease (AD, onset less than 65 years of age, n = 13) and senile dementia of the Alzheimer type (SDAT, onset greater than or equal to 65 years of age, n = 28) were investigated for cerebrospinal fluid (CSF) content of homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA) and 3-methoxy-4-hydroxy-phenylglycol (MHPG) and compared with a group of controls (n = 26)." | 3.67 | Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia. ( Blennow, K; Bråne, G; Gottfries, CG; Karlsson, I; Lekman, A; Parnetti, L; Svennerholm, L; Wallin, A, 1989) |
| "Mean levels of the two hydrolases angiotensin-converting enzyme (ACE) and acetylcholinesterase (AChE), the dopamine metabolites dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), and total protein concentration were examined in cerebrospinal fluid (CSF) samples from a group of patients with dementia of the Alzheimer's type, a group of comparably demented patients with Parkinson's disease, and a neurologically healthy elderly control group." | 3.67 | Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study. ( Direnfeld, LK; Langlais, PJ; Marquis, JK; Nixon, RA; Volicer, L; Zubenko, GS, 1986) |
| "Noradrenaline, dopamine, homovanillic acid (HVA), choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) levels were measured in post-mortem brains from 8 cases of pre-senile Alzheimer-type dementia (ATD), 5 cases of senile ATD, 4 cases of Down's syndrome aged 53-57 years, one 27-year-old case of Down's syndrome and 13 controls." | 3.66 | Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome. ( Allison, Y; Gordon, A; Maloney, AF; Ritchie, IM; Simpson, J; Urquhart, A; Yates, CM, 1983) |
| " Pharmacokinetic investigations showed that the oral bioavailability of tacrine was low and greatly varying between subjects." | 2.67 | Clinical experiences and biochemical findings with tacrine (THA). ( Ahlin, A; Hassan, M; Junthé, T; Nybäck, H, 1993) |
| "Abnormalities found in senile or presenile dementia were not always parallel to the age-related changes." | 2.38 | Senile dementia and presenile dementia. ( Nakamura, S, 1990) |
| "Patients with Alzheimer's disease (AD) have been reported to have a rate of nonsuppression on the dexamethasone suppression test (DST) comparable to that of patients with major depression." | 2.38 | The dexamethasone suppression test in Alzheimer's disease and major depression: relationship to dementia severity, depression, and CSF monoamines. ( Hill, JL; Lawlor, BA; Martinez, R; Mellow, AM; Molchan, SE; Sunderland, T, 1990) |
| "Dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) are the two most common causes of dementia." | 1.46 | Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study. ( Hatsuta, H; Kanemaru, K; Komiya, T; Morimoto, S; Murayama, S; Nakano, Y; Nishina, Y; Saito, Y; Sengoku, R; Sumikura, H; Takao, M; Uchino, A, 2017) |
| "Neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) are present during the disease course of nearly all AD patients and consist of psychosis, agitation/aggression, and depression, among others." | 1.40 | Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease. ( Aerts, T; De Deyn, PP; Engelborghs, S; Van Dam, D; Vermeiren, Y, 2014) |
| "Depression and aggression in Alzheimer's disease (AD) are 2 of the most severe and prominent neuropsychiatric symptoms (NPS)." | 1.40 | Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease. ( Aerts, T; De Deyn, PP; Engelborghs, S; Van Dam, D; Vermeiren, Y, 2014) |
| "Delirium is a complex neuropsychiatric syndrome with an acute onset and fluctuating course." | 1.33 | Abnormal neurotransmitter metabolite levels in Alzheimer patients with a delirium. ( Engelhart, MJ; Fekkes, D; Tiemeier, H; van der Cammen, TJ, 2006) |
| "Subjects with Alzheimer type dementia (AD), vascular dementia (VD), and controls without dementia (C) were investigated." | 1.30 | Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio. ( Wada, H, 1998) |
| "Distinguishing Alzheimer's disease from DLB is clinically relevant in terms of prognosis and appropriate treatment." | 1.30 | Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. ( Ballard, C; Burn, D; Court, JA; Jaros, E; Johnson, M; Lloyd, S; Marshall, EF; McKeith, IG; Perry, EK; Perry, RH; Piggott, MA; Thomas, N, 1999) |
| " In the second phase of this study the same 12 PDD patients were treated with GAP at a daily dosage of 250 lipasemic-releasing units for a period of 1 month and it was found that all four biochemical parameters shifted towards normal values during therapy with the changes in CSF 5-hydroxy-indole acetic acid levels attaining statistical significance." | 1.29 | Glycosaminoglycan polysulfate in primary degenerative dementia. Pilot study of biologic and clinical effects. ( Ban, TA; Parnetti, L; Senin, U, 1995) |
| "Patients with the Lewy body variant of Alzheimer's disease tended to experience more frequent extrapyramidal side effects of neuroleptics than did the patients with Alzheimer's disease, but for patients in the two groups who were not exposed to neuroleptics, there was little difference in frequency of extrapyramidal side effects." | 1.29 | Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases. ( Cullum, CM; Honig, L; Risser, RC; Rosenberg, RN; Speciale, S; Weiner, MF; White, C, 1996) |
| "In contrast to senile dementia of Alzheimer's type SLI was not correlated with dementia scores but with motor disease progression." | 1.28 | Parkinson's disease and dementia: clinical and neurochemical correlations. ( Cramer, H; Strittmatter, MM, 1992) |
| "Patients who had Alzheimer's disease-senile dementia of the Alzheimer type (AD/SDAT) or multi-infarct dementia (MID) were compared with a group of controls." | 1.27 | Dementia of the Alzheimer type and multi-infarct dementia: a clinical description and diagnostic problems. ( Adolfsson, R; Bucht, G; Winblad, B, 1984) |
| "Patients with Parkinson's disease have a decrement in homovanillic acid that is reversed by treatment with L-3,4-dihydroxyphenylalanine." | 1.27 | Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method. ( Aguado, EG; de Yebenes, JG; Mena, MA, 1984) |
| "The nbM from patients with Alzheimer's disease showed significant decreases in both spiperone binding and in the levels of dopamine and serotonin but no decrease in either tyrosine or tryptophan levels." | 1.27 | Alzheimer's disease: monoamines and spiperone binding reduced in nucleus basalis. ( Markesbery, WR; Slevin, JT; Sparks, DL, 1986) |
| "5-Hydroxyindoleacetic acid was significantly lower in patients with myoclonic DAT as compared to patients with nonmyoclonic DAT, but not significantly lower than in control subjects." | 1.27 | Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's disease. ( Atack, JR; Beal, MF; Daly, E; Friedland, RP; Kaufman, S; Kaye, JA; May, C; Milstien, S; Rapoport, SI; Sweeney, DL, 1988) |
| "It is concluded that in severe forms of senile dementia of Alzheimer type, there is a decrease in the levels of HVA and 5-HIAA in CSF which may reflect a decreased turnover of dopamine and serotonin." | 1.26 | Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type. ( MacDonald, E; Rekonen, M; Riekkinen, PJ; Soininen, H, 1981) |
| "The diagnosis of Alzheimer's disease (13 patients) and Pick's disease (4 patients) has been made on clinical and radiological grounds." | 1.26 | [Cerebral metabolism of dopamine and of serotonin during Alzheimer and Pick's diseases. Dynamic study by the test using probenecid]. ( Chazot, G; Guard, O; Renaud, B, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 53 (54.08) | 18.7374 |
| 1990's | 34 (34.69) | 18.2507 |
| 2000's | 7 (7.14) | 29.6817 |
| 2010's | 4 (4.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vermeiren, Y | 2 |
| Van Dam, D | 2 |
| Aerts, T | 2 |
| Engelborghs, S | 3 |
| De Deyn, PP | 3 |
| Esteban, G | 1 |
| Van Schoors, J | 1 |
| Sun, P | 1 |
| Van Eeckhaut, A | 1 |
| Marco-Contelles, J | 1 |
| Smolders, I | 1 |
| Unzeta, M | 1 |
| Morimoto, S | 1 |
| Takao, M | 1 |
| Hatsuta, H | 1 |
| Nishina, Y | 1 |
| Komiya, T | 1 |
| Sengoku, R | 1 |
| Nakano, Y | 1 |
| Uchino, A | 1 |
| Sumikura, H | 1 |
| Saito, Y | 1 |
| Kanemaru, K | 2 |
| Murayama, S | 1 |
| Svennerholm, L | 4 |
| Bråne, G | 2 |
| Karlsson, I | 3 |
| Lekman, A | 2 |
| Ramström, I | 1 |
| Wikkelsö, C | 2 |
| Sjögren, M | 1 |
| Ostling, S | 1 |
| Wallin, A | 2 |
| Blennow, K | 2 |
| Yamanouchi, H | 1 |
| Vloeberghs, E | 1 |
| Maertens, K | 1 |
| Marescau, B | 1 |
| Stuerenburg, HJ | 1 |
| Ganzer, S | 1 |
| Müller-Thomsen, T | 1 |
| van der Cammen, TJ | 1 |
| Tiemeier, H | 1 |
| Engelhart, MJ | 1 |
| Fekkes, D | 1 |
| Muramoto, O | 1 |
| Ando, K | 1 |
| Nakamura, S | 3 |
| Koshimura, K | 1 |
| Kato, T | 1 |
| Yamao, S | 1 |
| Iijima, S | 1 |
| Nagata, H | 1 |
| Miyata, S | 2 |
| Fujiyoshi, K | 1 |
| Okamoto, K | 1 |
| Suga, H | 1 |
| Argentiero, V | 1 |
| Tavolato, B | 1 |
| Soininen, H | 2 |
| MacDonald, E | 1 |
| Rekonen, M | 1 |
| Riekkinen, PJ | 4 |
| Bareggi, SR | 1 |
| Franceschi, M | 1 |
| Bonini, L | 1 |
| Zecca, L | 1 |
| Smirne, S | 1 |
| Wood, PL | 1 |
| Etienne, P | 1 |
| Lal, S | 1 |
| Gauthier, S | 1 |
| Cajal, S | 1 |
| Nair, NP | 1 |
| Gottfries, CG | 8 |
| Adolfsson, R | 5 |
| Aquilonius, SM | 1 |
| Carlsson, A | 2 |
| Eckernäs, SA | 1 |
| Nordberg, A | 1 |
| Oreland, L | 1 |
| Wiberg, A | 1 |
| Winblad, B | 4 |
| Bucht, G | 1 |
| Palmer, AM | 4 |
| Sims, NR | 2 |
| Bowen, DM | 6 |
| Neary, D | 4 |
| Palo, J | 1 |
| Wikstrom, J | 1 |
| Davison, AN | 2 |
| Mena, MA | 1 |
| Aguado, EG | 1 |
| de Yebenes, JG | 1 |
| Losonczy, MF | 1 |
| Mohs, RC | 3 |
| Davis, KL | 3 |
| Yates, CM | 2 |
| Simpson, J | 2 |
| Gordon, A | 2 |
| Maloney, AF | 1 |
| Allison, Y | 1 |
| Ritchie, IM | 1 |
| Urquhart, A | 1 |
| Cross, AJ | 1 |
| Crow, TJ | 1 |
| Ferrier, IN | 1 |
| Johnson, JA | 1 |
| Markakis, D | 1 |
| Direnfeld, LK | 3 |
| Albert, ML | 3 |
| Volicer, L | 4 |
| Langlais, PJ | 4 |
| Marquis, J | 1 |
| Kaplan, E | 1 |
| Zimmer, R | 1 |
| Teelken, AW | 1 |
| Trieling, WB | 1 |
| Weber, W | 1 |
| Weihmayr, T | 1 |
| Lauter, H | 1 |
| Mann, JJ | 1 |
| Stanley, M | 3 |
| Neophytides, A | 1 |
| de Leon, MJ | 1 |
| Ferris, SH | 1 |
| Gershon, S | 1 |
| Benton, JS | 2 |
| Curzon, G | 1 |
| Thomas, DJ | 2 |
| Nybäck, H | 3 |
| Hassan, M | 1 |
| Junthé, T | 1 |
| Ahlin, A | 1 |
| Parnetti, L | 3 |
| Ban, TA | 1 |
| Senin, U | 1 |
| Francis, PT | 3 |
| Pangalos, MN | 1 |
| Stephens, PH | 1 |
| Bartlett, JR | 1 |
| Bridges, PK | 1 |
| Malizia, AL | 1 |
| Procter, AW | 2 |
| Alhainen, K | 1 |
| Helkala, EL | 3 |
| Reinikainen, K | 1 |
| Riekkinen, P | 1 |
| Thal, L | 1 |
| Hansen, L | 1 |
| Galasko, D | 1 |
| Alford, M | 1 |
| Masliah, E | 1 |
| Bierer, LM | 1 |
| Knott, PJ | 1 |
| Schmeidler, JM | 1 |
| Marin, DB | 1 |
| Ryan, TM | 1 |
| Haroutunian, V | 1 |
| Purohit, DP | 1 |
| Perl, DP | 1 |
| Weiner, MF | 1 |
| Risser, RC | 1 |
| Cullum, CM | 1 |
| Honig, L | 1 |
| White, C | 1 |
| Speciale, S | 1 |
| Rosenberg, RN | 1 |
| Strittmatter, M | 1 |
| Hamann, G | 1 |
| Cramer, H | 2 |
| Reuner, C | 1 |
| Kuntzmann, F | 1 |
| Strubel, D | 1 |
| Sweet, RA | 1 |
| Pollock, BG | 1 |
| Mulsant, BH | 1 |
| Rosen, J | 1 |
| Lo, KH | 1 |
| Yao, JK | 1 |
| Henteleff, RA | 1 |
| Mazumdar, S | 1 |
| Sheline, YI | 1 |
| Miller, K | 1 |
| Bardgett, ME | 1 |
| Csernansky, JG | 1 |
| Wada, H | 1 |
| Hoogendijk, WJ | 1 |
| Feenstra, MG | 1 |
| Botterblom, MH | 1 |
| Gilhuis, J | 1 |
| Sommer, IE | 1 |
| Kamphorst, W | 1 |
| Eikelenboom, P | 1 |
| Swaab, DF | 1 |
| Piggott, MA | 1 |
| Marshall, EF | 1 |
| Thomas, N | 1 |
| Lloyd, S | 1 |
| Court, JA | 1 |
| Jaros, E | 1 |
| Burn, D | 1 |
| Johnson, M | 1 |
| Perry, RH | 1 |
| McKeith, IG | 1 |
| Ballard, C | 1 |
| Perry, EK | 2 |
| del Ser, T | 1 |
| Davies, P | 1 |
| Roos, BE | 2 |
| Meyer, JS | 1 |
| Welch, KM | 1 |
| Deshmukh, VD | 1 |
| Perez, FI | 1 |
| Jacob, RH | 1 |
| Haufrect, DB | 1 |
| Mathew, NT | 1 |
| Morrell, RM | 1 |
| Guard, O | 1 |
| Renaud, B | 1 |
| Chazot, G | 1 |
| Siever, L | 1 |
| Kraemer, H | 1 |
| Sack, R | 1 |
| Angwin, P | 1 |
| Berger, P | 1 |
| Zarcone, V | 1 |
| Barchas, J | 1 |
| Brodie, HK | 1 |
| Pomara, N | 2 |
| LeWitt, PA | 2 |
| Galloway, M | 1 |
| Singh, R | 1 |
| Deptula, D | 2 |
| Nazarali, AJ | 1 |
| Reynolds, GP | 2 |
| Laulumaa, V | 1 |
| Hartikainen, P | 1 |
| Strittmatter, MM | 1 |
| Arai, H | 1 |
| Ichimiya, Y | 1 |
| Kosaka, K | 1 |
| Moroji, T | 1 |
| Iizuka, R | 1 |
| Lee, S | 1 |
| Chiba, T | 1 |
| Kitahama, T | 1 |
| Kaieda, R | 1 |
| Hagiwara, M | 1 |
| Nagazumi, A | 1 |
| Terashi, A | 1 |
| Kawakatsu, S | 1 |
| Morinobu, S | 1 |
| Shinohara, M | 1 |
| Totsuka, S | 1 |
| Kobashi, K | 1 |
| Nyth, AL | 1 |
| Malm, J | 1 |
| Kristensen, B | 1 |
| Ekstedt, J | 1 |
| Wester, P | 1 |
| Martignoni, E | 1 |
| Bono, G | 1 |
| Blandini, F | 1 |
| Sinforiani, E | 1 |
| Merlo, P | 1 |
| Nappi, G | 1 |
| Molchan, SE | 3 |
| Hill, JL | 2 |
| Mellow, AM | 3 |
| Lawlor, BA | 3 |
| Martinez, R | 1 |
| Sunderland, T | 5 |
| Martinez, RA | 2 |
| Davis, CL | 1 |
| Rubinow, DR | 1 |
| Berrettini, WH | 1 |
| Vitiello, B | 1 |
| Tariot, PN | 2 |
| Cohen, RM | 2 |
| Nyman, H | 2 |
| Blomqvist, G | 1 |
| Sjögren, I | 1 |
| Stone-Elander, S | 1 |
| McKeith, I | 1 |
| Thompson, P | 1 |
| Marshall, E | 1 |
| Kerwin, J | 1 |
| Jabeen, S | 1 |
| Edwardson, JA | 1 |
| Ince, P | 1 |
| Blessed, G | 1 |
| Irving, D | 1 |
| Liu, HC | 1 |
| Yang, JC | 1 |
| Chang, YF | 1 |
| Liu, TY | 1 |
| Chi, CW | 1 |
| Allard, P | 1 |
| Alafuzoff, I | 1 |
| Eriksson, K | 1 |
| Ericson, E | 1 |
| Marcusson, JO | 1 |
| Tyrrell, PJ | 1 |
| Sawle, GV | 1 |
| Ibanez, V | 1 |
| Bloomfield, PM | 1 |
| Leenders, KL | 1 |
| Frackowiak, RS | 1 |
| Rossor, MN | 1 |
| Wolfe, N | 1 |
| Katz, DI | 1 |
| Almozlino, A | 1 |
| Durso, R | 1 |
| Smith, MC | 1 |
| Seeldrayers, P | 1 |
| Messina, D | 1 |
| Desmedt, D | 1 |
| Dalesio, O | 1 |
| Hildebrand, J | 1 |
| Cutler, NR | 2 |
| Haxby, J | 1 |
| Kay, AD | 3 |
| Narang, PK | 1 |
| Lesko, LJ | 1 |
| Costa, JL | 1 |
| Ninos, M | 1 |
| Linnoila, M | 1 |
| Potter, WZ | 2 |
| Renfrew, JW | 1 |
| Davis, BM | 1 |
| Greenwald, BS | 1 |
| Mathé, AA | 1 |
| Johns, CA | 1 |
| Horvath, TB | 1 |
| Degrell, I | 1 |
| Pék, G | 1 |
| Nagy, D | 1 |
| Nagy, E | 1 |
| Hoyer, S | 1 |
| Sparks, DL | 1 |
| Markesbery, WR | 1 |
| Slevin, JT | 1 |
| Milstien, S | 3 |
| Kaufman, S | 3 |
| Creasey, H | 1 |
| Haxby, JV | 1 |
| Rapoport, SI | 2 |
| Wilcock, GK | 1 |
| Esiri, MM | 1 |
| Newhouse, PA | 1 |
| Mueller, EA | 1 |
| Murphy, DL | 1 |
| Mayeux, R | 1 |
| Stern, Y | 1 |
| Sano, M | 1 |
| Cote, L | 1 |
| Williams, JB | 1 |
| Gottfries, J | 1 |
| Långström, G | 1 |
| Godridge, H | 1 |
| Czudek, C | 1 |
| Calcutt, NA | 1 |
| Benton, M | 1 |
| Risby, ED | 1 |
| Hsiao, JK | 1 |
| Agren, H | 1 |
| Rudorfer, MV | 1 |
| Schalling, D | 1 |
| Kaye, JA | 2 |
| May, C | 2 |
| Daly, E | 2 |
| Atack, JR | 2 |
| Sweeney, DJ | 1 |
| Luxenberg, JS | 1 |
| Friedland, RP | 2 |
| Koyama, E | 1 |
| Minegishi, A | 1 |
| Ishizaki, T | 1 |
| Stratmann, GC | 1 |
| Freed, DM | 1 |
| Corkin, S | 1 |
| Growdon, JH | 2 |
| Nissen, MJ | 1 |
| Sweeney, DL | 1 |
| Beal, MF | 1 |
| Jolkkonen, J | 1 |
| Kutvonen, R | 1 |
| Lehtinen, M | 1 |
| Singh, RR | 1 |
| Bissette, G | 1 |
| Nemeroff, CB | 1 |
| Corona, GL | 1 |
| Cucchi, ML | 1 |
| Frattini, P | 1 |
| Santagostino, G | 1 |
| Schinelli, S | 1 |
| Romani, A | 1 |
| Pola, A | 1 |
| Zerbi, F | 1 |
| Savoldi, F | 1 |
| Gibson, CJ | 1 |
| Logue, M | 1 |
| Shigetomi, S | 1 |
| Jolkkonen, JT | 1 |
| Soininen, HS | 1 |
| Freedman, M | 1 |
| Bird, ED | 1 |
| Zubenko, GS | 1 |
| Marquis, JK | 1 |
| Nixon, RA | 1 |
| Mann, DM | 1 |
| Snowden, JS | 1 |
4 reviews available for homovanillic acid and Alzheimer Disease
| Article | Year |
|---|---|
[Biogenic amines and aging (author's transl)].
Topics: Adult; Aged; Aging; Alzheimer Disease; Biogenic Amines; Brain; Catecholamines; Homovanillic Acid; Hu | 1981 |
[Clinical manifestation of frontotemporal dementia].
Topics: Alzheimer Disease; Atrophy; Cognition Disorders; Diagnosis, Differential; Frontal Lobe; Homovanillic | 2000 |
Senile dementia and presenile dementia.
Topics: Acetylcholinesterase; Alzheimer Disease; Arginine Vasopressin; Biopterins; Brain Chemistry; Cerebral | 1990 |
The dexamethasone suppression test in Alzheimer's disease and major depression: relationship to dementia severity, depression, and CSF monoamines.
Topics: Aged; Alzheimer Disease; Depressive Disorder; Dexamethasone; Female; Homovanillic Acid; Humans; Hydr | 1990 |
9 trials available for homovanillic acid and Alzheimer Disease
| Article | Year |
|---|---|
Alzheimer disease - effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme.
Topics: Aged; Alzheimer Disease; Cerebrovascular Circulation; Female; G(M1) Ganglioside; Homovanillic Acid; | 2002 |
Clinical experiences and biochemical findings with tacrine (THA).
Topics: Administration, Rectal; Alzheimer Disease; Biogenic Monoamines; Cross-Sectional Studies; Double-Blin | 1993 |
Neurochemical parameters in senile dementia of the Alzheimer type. A longitudinal study in four cases.
Topics: Alzheimer Disease; Antidepressive Agents; Antipsychotic Agents; Brain Chemistry; Homovanillic Acid; | 1996 |
Association of plasma homovanillic acid with behavioral symptoms in patients diagnosed with dementia: a preliminary report.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Behavior; Dyskinesia, Drug-Induced | 1997 |
The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.
Topics: Affective Symptoms; Aged; Alzheimer Disease; Citalopram; Dementia, Multi-Infarct; Double-Blind Metho | 1990 |
Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl.
Topics: Aged; Alzheimer Disease; Biogenic Monoamines; Cognition; Dopamine; Double-Blind Method; Epinephrine; | 1991 |
Evaluation of zimeldine in Alzheimer's disease. Cognitive and biochemical measures.
Topics: Aged; Alzheimer Disease; Blood Platelets; Clinical Trials as Topic; Double-Blind Method; Homovanilli | 1985 |
Clinical and biochemical responses to therapy in Alzheimer's disease and multi-infarct dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arousal; Blood Pressure; Choline; Clinical Trials as Top | 1989 |
The effect of ACTH4-9 analog (Org2766) on some cerebrospinal fluid parameters in patients with Alzheimer's disease.
Topics: Adrenocorticotropic Hormone; Aged; Alzheimer Disease; Cholinesterases; Cyclic AMP; Dopamine beta-Hyd | 1985 |
85 other studies available for homovanillic acid and Alzheimer Disease
| Article | Year |
|---|---|
Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Alzheimer Disease; Autopsy; Biogenic Monoam | 2014 |
Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Brain; Chromatography, High Pressure Liquid; | 2014 |
In-vitro and in-vivo evaluation of the modulatory effects of the multitarget compound ASS234 on the monoaminergic system.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alzheimer Disease; Animals; Biogenic Monoamines; Cell Line, Tumor; D | 2017 |
Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Autopsy; Biomarkers; Diagn | 2017 |
Biological correlates of clinical subgroups of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Biomarkers; Brain; | 2002 |
Assessment of CSF homovanillic acid levels distinguishes dementia with Lewy bodies from Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Diagnosis, Differential; Female; Homovanillic Acid; Humans; Lewy Body Disea | 2002 |
Evidence for an association between the CSF HVA:5-HIAA ratio and aggressiveness in frontotemporal dementia but not in Alzheimer's disease.
Topics: Aged; Aggression; Alzheimer Disease; Dementia; Diagnosis, Differential; Follow-Up Studies; Frontal L | 2004 |
5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
Topics: Aged; Alzheimer Disease; Cognition Disorders; Depression; Dopamine; Female; Homovanillic Acid; Human | 2004 |
Abnormal neurotransmitter metabolite levels in Alzheimer patients with a delirium.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amino Acids; Case-Control Studies; Delirium; Female; Hom | 2006 |
Neurotransmitters in dementia.
Topics: Adult; Aged; Alzheimer Disease; Arginine Vasopressin; Biopterins; Central Nervous System; Cerebral C | 1984 |
Dopamine (DA) and serotonin metabolic levels in the cerebrospinal fluid (CSF) in Alzheimer's presenile dementia under basic conditions and after stimulation with cerebral cortex phospholipids (BC-PL).
Topics: Alzheimer Disease; Cerebral Cortex; Dementia; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacet | 1980 |
Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Topics: Aged; Alzheimer Disease; Butyrophenones; Dementia; Homovanillic Acid; Humans; Hydroxyindoleacetic Ac | 1981 |
Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer's disease. Age- or disease-related modifications?
Topics: Age Factors; Aged; Aging; Alzheimer Disease; Brain Chemistry; Dementia; Female; gamma-Aminobutyric A | 1982 |
Reduced lumbar CSF somatostatin levels in Alzheimer's disease.
Topics: Aged; Alcohol Amnestic Disorder; Alzheimer Disease; Dementia; Female; Homovanillic Acid; Humans; Hyd | 1982 |
Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT).
Topics: Aged; Alzheimer Disease; Brain; Choline O-Acetyltransferase; Female; Gangliosides; Homovanillic Acid | 1983 |
Dementia of the Alzheimer type and multi-infarct dementia: a clinical description and diagnostic problems.
Topics: Aged; Alzheimer Disease; Blood Chemical Analysis; Cardiovascular Diseases; Dementia; Diagnosis, Diff | 1984 |
Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
Topics: Aged; Alzheimer Disease; Brain; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid | 1984 |
Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alzheimer Disease; Chromatography, High Pressure Liquid; Depression; | 1984 |
Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations.
Topics: Adult; Alzheimer Disease; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxy | 1984 |
Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.
Topics: Acetylcholinesterase; Adult; Aged; Aging; Alzheimer Disease; Brain; Choline O-Acetyltransferase; Dem | 1983 |
Striatal dopamine receptors in Alzheimer-type dementia.
Topics: Aged; Alzheimer Disease; Choline O-Acetyltransferase; Dementia; Female; gamma-Aminobutyric Acid; Hom | 1984 |
Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings.
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Cognition; Dementia; Functional Laterality; Homovanil | 1984 |
Gamma-aminobutyric acid and homovanillic acid concentration in the CSF of patients with senile dementia of Alzheimer's type.
Topics: Aged; Alzheimer Disease; Dementia; Female; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Middl | 1984 |
Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficit.
Topics: Aged; Alzheimer Disease; Blood Platelets; Cognition Disorders; Dementia; Glycols; Homovanillic Acid; | 1981 |
Treatment of Alzheimer's disease: a cautionary note.
Topics: Adult; Aged; Alzheimer Disease; Dementia; Homovanillic Acid; Humans; Male; Middle Aged | 1981 |
Glycosaminoglycan polysulfate in primary degenerative dementia. Pilot study of biologic and clinical effects.
Topics: Aged; Alzheimer Disease; Blood Platelets; Female; Glycosaminoglycans; Homovanillic Acid; Humans; Hyd | 1995 |
Antemortem measurements of neurotransmission: possible implications for pharmacotherapy of Alzheimer's disease and depression.
Topics: Adult; Alzheimer Disease; Antidepressive Agents; Antipsychotic Agents; Cerebral Ventricles; Female; | 1993 |
The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Biogenic Monoamines; Female; | 1993 |
Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alzheimer Disease; Basal Ganglia; Brain; Brain Chemistry; Caudate Nu | 1993 |
Post-mortem examination of dopaminergic parameters in Alzheimer's disease: relationship to noncognitive symptoms.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Alzheimer Disease; Dopamine; Female; Homova | 1993 |
Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Basal Ganglia Diseases; Body Height; Delusions; Diagn | 1996 |
Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type. Relationship with cognitive dysfunction.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Female; Homovanillic Acid; Humans; | 1998 |
Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio.
Topics: Aged; Aged, 80 and over; Albumins; alpha 1-Antichymotrypsin; Alzheimer Disease; Blood-Brain Barrier; | 1998 |
Increased activity of surviving locus ceruleus neurons in Alzheimer's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alzheimer Disease; Amygdala; Cell Count; Cell Survival; Dopamine; Fe | 1999 |
Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autoradiography; Corpus Striatum; Dementia; Dopamine; Fe | 1999 |
Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
Topics: Acetylcholine; Acetylcholinesterase; Aged; Alzheimer Disease; Brain; Choline O-Acetyltransferase; De | 1979 |
Cathecholamines in the human brain and ageing.
Topics: Aged; Aging; Alzheimer Disease; Autopsy; Brain; Dementia; Dopamine; Homovanillic Acid; Humans; Norep | 1977 |
Neurotransmitter precursor amino acids in the treatment of multi-infarct dementia and Alzheimer's disease.
Topics: 5-Hydroxytryptophan; Aged; Alzheimer Disease; Carbidopa; Dementia; Dopamine; Drug Combinations; Fema | 1977 |
Changes in the brain catecholamines in patients with dementia of Alzheimer type.
Topics: Aged; Alzheimer Disease; Brain; Catecholamines; Dementia; Dopamine; Female; Homovanillic Acid; Human | 1979 |
[Cerebral metabolism of dopamine and of serotonin during Alzheimer and Pick's diseases. Dynamic study by the test using probenecid].
Topics: Aged; Alzheimer Disease; Brain Chemistry; Dementia; Dopamine; Female; Homovanillic Acid; Humans; Hyd | 1976 |
Gradients of biogenic amine metabolites in cerebrospinal fluid.
Topics: Alzheimer Disease; Amphetamine; Brain Diseases; Brain Neoplasms; Depression; Homovanillic Acid; Huma | 1975 |
Increased CSF HVA response to arecoline challenge in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Arecoline; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mal | 1992 |
Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amygdala; Brain Chemistry; Caudate Nucleus; Dementia; Do | 1992 |
Extrapyramidal signs in Alzheimer's disease: a 3-year follow-up study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Basal Ganglia Diseases; Dopamine; | 1992 |
Parkinson's disease and dementia: clinical and neurochemical correlations.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic A | 1992 |
Neurotransmitter changes in early- and late-onset Alzheimer-type dementia.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain Chemistry; Choline O-Acetyltransferase; Hom | 1992 |
5-Hydroxytryptamine and dopamine in pre-senile and senile Alzheimer-type dementia.
Topics: Age Factors; Aged; Alzheimer Disease; Amygdala; Brain; Caudate Nucleus; Dopamine; Homovanillic Acid; | 1990 |
CSF beta-endorphin, HVA and 5-HIAA of dementia of the Alzheimer type and Binswanger's disease in the elderly.
Topics: Alzheimer Disease; beta-Endorphin; Dementia; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic | 1990 |
Acetylcholinesterase activities and monoamine metabolite levels in the cerebrospinal fluid of patients with Alzheimer's disease.
Topics: Acetylcholinesterase; Adult; Aged; Alzheimer Disease; Brain; Butyrylcholinesterase; Cerebral Ventric | 1990 |
CSF monoamine metabolites, cholinesterases and lactate in the adult hydrocephalus syndrome (normal pressure hydrocephalus) related to CSF hydrodynamic parameters.
Topics: Aged; Alzheimer Disease; Cerebrospinal Fluid Pressure; Cholinesterases; Dementia, Multi-Infarct; Fem | 1991 |
CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
Topics: Aged; Alzheimer Disease; Depressive Disorder; Diagnosis, Differential; Female; Homovanillic Acid; Hu | 1991 |
Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Depressive Disorder; Dynorphins; Female; Galanin; Homovanillic Acid; | 1991 |
Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects.
Topics: Aged; Alzheimer Disease; Blood Glucose; Brain; Brain Mapping; Cerebral Cortex; Deoxyglucose; Dominan | 1991 |
Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Cerebral Cortex; Choline O-Acetyltransferase; Dementia; Hallucinatio | 1991 |
Analysis of monoamines in the cerebrospinal fluid of Chinese patients with Alzheimer's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alzheimer Disease; China; Chromatography, High Pressure Liquid; Dihy | 1991 |
Loss of dopamine uptake sites labeled with [3H]GBR-12935 in Alzheimer's disease.
Topics: Aged; alpha-Methyltyrosine; Alzheimer Disease; Dopamine; Female; Homovanillic Acid; Humans; In Vitro | 1990 |
Clinical and positron emission tomographic studies in the 'extrapyramidal syndrome' of dementia of the Alzheimer type.
Topics: Adult; Aged; Alzheimer Disease; Caudate Nucleus; Dementia; Dopamine; Homovanillic Acid; Humans; Midd | 1990 |
Neuropsychological profile linked to low dopamine: in Alzheimer's disease, major depression, and Parkinson's disease.
Topics: Aged; Alzheimer Disease; Attention; Depressive Disorder; Dopamine; Homovanillic Acid; Humans; Male; | 1990 |
CSF levels of neurotransmitters in Alzheimer-type dementia. Effects of ergoloid mesylate.
Topics: Aged; Alzheimer Disease; Dihydroergotoxine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic A | 1985 |
Clinical studies of the cholinergic deficit in Alzheimer's disease. I. Neurochemical and neuroendocrine studies.
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Choline; Choline Deficiency; Cognition; Female; Gas C | 1985 |
Dementias, psychological tests, and neurotransmitters.
Topics: Aged; Alcoholism; Alzheimer Disease; Dementia; Diagnosis, Differential; Female; Homovanillic Acid; H | 1985 |
Alzheimer's disease: monoamines and spiperone binding reduced in nucleus basalis.
Topics: Aged; Alzheimer Disease; Basal Ganglia; Biogenic Amines; Dopamine; Homovanillic Acid; Humans; Hydrox | 1986 |
Cerebrospinal fluid biopterin is decreased in Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Biopterins; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindo | 1986 |
Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Biogenic Amines; | 1987 |
Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Biogenic Amines; Dose-Response Relationship, Drug; Homovanillic Acid; Huma | 1987 |
Clinical and biochemical correlates of bradyphrenia in Parkinson's disease.
Topics: Aged; Alzheimer Disease; Arousal; Attention; Biogenic Amines; Cognition Disorders; Homovanillic Acid | 1987 |
Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography-mass spectrometry.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biogenic Amines; Chromatography, High Pressure Liquid; G | 1987 |
Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.
Topics: Acetylcholine; Adult; Age Factors; Alzheimer Disease; Brain; Choline O-Acetyltransferase; Dopamine; | 1987 |
The effects of antidepressants on the cerebrospinal fluid homovanillic acid/5-hydroxyindoleacetic acid ratio.
Topics: Alzheimer Disease; Antidepressive Agents; Cerebrospinal Fluid; Depressive Disorder; Drug Evaluation; | 1987 |
Neuropsychological test performance and CSF levels of monoamine metabolites in healthy volunteers and patients with Alzheimer's dementia.
Topics: Aged; Alzheimer Disease; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; | 1987 |
Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features.
Topics: Aged; Alzheimer Disease; Biopterins; Dementia; Female; Homovanillic Acid; Humans; Hydroxyindoleaceti | 1988 |
Simultaneous determination of four monoamine metabolites and serotonin in cerebrospinal fluid by "high-performance" liquid chromatography with electrochemical detection; application for patients with Alzheimer's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alzheimer Disease; Chromatography, High Pressure Liquid; Electrochem | 1988 |
Possible neurotransmitter basis of behavioral changes in Alzheimer's disease.
Topics: Acetylcholine; Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; gamma-Aminobutyric Acid; | 1988 |
Selective attention in Alzheimer's disease: CSF correlates of behavioral impairments.
Topics: Aged; Alzheimer Disease; Attention; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic | 1988 |
Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's disease.
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Analysis of Variance; Biopterins; Female; Homovanilli | 1988 |
Vasopressin levels in CSF of Alzheimer patients: correlations with monoamine metabolites and neuropsychological test performance.
Topics: Aged; Alzheimer Disease; Arginine Vasopressin; Female; Glycols; Homovanillic Acid; Humans; Hydroxyin | 1989 |
Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.
Topics: Aged; Alzheimer Disease; Behavior; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic A | 1989 |
CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: its relationship to severity of dementia and monoamine metabolites.
Topics: Aged; Alzheimer Disease; Corticotropin-Releasing Hormone; Disability Evaluation; Female; Homovanilli | 1989 |
Neurotransmitters in the brains of patients with dementia disorders.
Topics: Acetylcholine; Aged; Alzheimer Disease; Brain; Choline O-Acetyltransferase; Dementia; Dopamine; Glut | 1985 |
CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease.
Topics: Adult; Aged; Alzheimer Disease; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid | 1985 |
[Clinical significance of homovanillic acid analysis in endocrine tests of the adrenal medulla and sympathetic nervous system].
Topics: Adrenal Medulla; Alzheimer Disease; Chromatography, High Pressure Liquid; Homovanillic Acid; Humans; | 1989 |
[Ageing and neurotransmitters].
Topics: Acetylcholine; Aged; Aging; Alzheimer Disease; Animals; Brain; Choline O-Acetyltransferase; Dopamine | 1985 |
Catecholamine metabolites and cyclic nucleotides in cerebrospinal fluid in dementia of Alzheimer type.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Alzheimer Disease; Catecholamines; Cyclic AMP; Cyclic GMP; Hom | 1985 |
Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholinesterase; Aged; Alzheimer Disease; Cerebrospinal Fluid P | 1986 |
Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Catecholamines; Cerebral Cortex; Choline O-Acetyltransferase; Cognit | 1987 |